Correlation Between Laboratory and Bone Biologics

Can any of the company-specific risk be diversified away by investing in both Laboratory and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Laboratory and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Laboratory of and Bone Biologics Corp, you can compare the effects of market volatilities on Laboratory and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Laboratory with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Laboratory and Bone Biologics.

Diversification Opportunities for Laboratory and Bone Biologics

-0.55

Correlation Coefficient

Laboratory  Bone Biologics

Excellent diversification

The 3 months correlation between Laboratory and Bone is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Laboratory of and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Laboratory is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Laboratory of are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Laboratory i.e., Laboratory and Bone Biologics go up and down completely randomly.

Pair Corralation between Laboratory and Bone Biologics

Allowing for the 90-day total investment horizon Laboratory of is expected to generate 0.12 times more return on investment than Bone Biologics. However, Laboratory of is 8.48 times less risky than Bone Biologics. It trades about 0.03 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about -0.03 per unit of risk. If you would invest  21,118  in Laboratory of on September 3, 2024 and sell it today you would earn a total of  2,945  from holding Laboratory of or generate 13.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Laboratory of  vs.  Bone Biologics Corp

Laboratory

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Laboratory of are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong technical indicators, Laboratory is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Bone Biologics Corp

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Laboratory and Bone Biologics

The main advantage of trading using opposite Laboratory and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Laboratory position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.

The idea behind Laboratory of and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.